| Description: |
circARHGAP12 is up-regulated in osteosarcoma (including DOX-resistant cells) and promotes doxorubicin resistance, proliferation, and aerobic glycolysis. Mechanistically, its m6A modification enables binding to c-Myc mRNA and increases c-Myc mRNA stability, contributing to chemoresistance-associated metabolic reprogramming. |